Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 5/20 | 1.00 |
| ▸ | TP53 | P04637 | 5/20 | 1.00 |
| ▸ | LMNA | P02545 | 4/20 | 1.00 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 1.00 |
| ▸ | RAB9A | P51151 | 4/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 3/20 | 1.00 |
| ▸ | HIF1A | Q16665 | 3/20 | 1.00 |
| ▸ | NPC1 | O15118 | 3/20 | 1.00 |
| ▸ | NFKB1 | P19838 | 3/20 | 1.00 |
| ▸ | THPO | P40225 | 3/20 | 1.00 |
| ▸ | GMNN | O75496 | 3/20 | 1.00 |
| ▸ | PMP22 | Q01453 | 3/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 2/20 | 1.00 |
| ▸ | MTOR | P42345 | 2/20 | 1.00 |
| ▸ | BLM | P54132 | 2/20 | 1.00 |
| ▸ | PPM1B | O75688 | 2/20 | 1.00 |
| ▸ | PPP1CC | P36873 | 2/20 | 1.00 |
| ▸ | TFPI2 | P48307 | 2/20 | 1.00 |
| ▸ | PPP5C | P53041 | 2/20 | 1.00 |
| ▸ | PPP1CA | P62136 | 2/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cantharidin SCHEMBL152262 | 1.00 | MAPK1 (1.00) | MAPK1TP53LMNASMN1; SMN2RAB9A | |
| Cantharidin SCHEMBL14120808 | 1.00 | MAPK1 (1.00) | MAPK1TP53LMNASMN1; SMN2RAB9A | |
| Cantharidin SCHEMBL1805181 | 1.00 | MAPK1 (1.00) | MAPK1TP53LMNASMN1; SMN2RAB9A | |
| SCHEMBL20885000 | 0.84 | MAPK1 (0.71) | MAPK1TP53LMNASMN1; SMN2RAB9A | |
| SCHEMBL24129015 | 0.81 | MAPK1 (0.67) | MAPK1TP53LMNASMN1; SMN2RAB9A | |
| SCHEMBL19619602 | 0.81 | MAPK1 (0.67) | MAPK1TP53LMNASMN1; SMN2RAB9A | |
| SCHEMBL20618517 | 0.78 | MAPK1 (0.62) | MAPK1TP53LMNASMN1; SMN2RAB9A | |
| SCHEMBL23080410 | 0.75 | TP53 (0.57) | MAPK1TP53LMNASMN1; SMN2RAB9A | |
| SCHEMBL3496407 | 0.74 | MAPK1 (0.59) | MAPK1TP53LMNASMN1; SMN2RAB9A | |
| SCHEMBL14025795 | 0.73 | MAPK1 (0.57) | MAPK1TP53LMNASMN1; SMN2RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 5775 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12635710-B2 | Methods of using formaldehyde-free antimicrobial compositions in animal by-product compositions | EASTMAN CHEMICAL COMPANY (US) | 2026-05-26 | — | — | US | claimed |
| US-20250332393-A1 | DEVICES AND METHODS FOR THE TREATMENT OF BODY SURFACE DISORDERS | VERRICA PHARMACEUTICALS INC. (US) | 2025-10-30 | — | — | US | claimed |
| US-20250302794-A1 | COMPOSITIONS, METHODS AND SYSTEMS FOR THE TREATMENT OF CUTANEOUS DISORDERS | VERRICA PHARMACEUTICALS INC. (US) | 2025-10-02 | — | — | US | claimed |
| US-20250262167-A1 | COMPOUNDS, TARGETS AND PATHWAYS FOR MACROPHAGE MODULATION | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 2025-08-21 | — | — | US | claimed |
| US-12343351-B2 | Pulmonary function treatment | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2025-07-01 | — | — | US | claimed |
| WO-2025129271-A1 | LIPID DELIVERY VEHICLE | THE UNIVERSITY OF QUEENSLAND (AU) | 2025-06-26 | — | — | WO | claimed |
| EP-3966344-B1 | KINASE SCREENING ASSAYS | UNIV NEWCASTLE (GB) | 2025-06-25 | — | — | EP | claimed |
| WO-2025125890-A1 | PROTEIN PHOSPHATASE 2A (PPA2) ANTAGONISTS FOR DENGUE TREATMENT | CENTRO DE INVESTIGACIÓN Y DE ESTUDIOS AVANZADOS DEL I.P.N. (MX) | 2025-06-19 | — | — | WO | claimed |
| CN-119950436-A | Deep penetration sequential targeting delivery composition and preparation method and application thereof | 杭州市西溪医院 | 2025-05-09 | — | — | CN | claimed |
| EP-3914286-B1 | METHODS OF MITIGATING TOXIC EFFECTS OF VESICANTS AND CAUSTIC GAS | JANSSEN PHARMACEUTICA NV (BE) | 2025-05-07 | — | — | EP | claimed |
| CN-1091953-A | Cantharidate anti-virus formulation and preparation thereof | WANG YUEWEI (CN) | 1994-09-14 | — | — | CN | claimed |
| CN-1076111-A | Cantharidate anti-virus formulation and preparation thereof | WANG RIWEI (CN) | 1993-09-15 | — | — | CN | claimed |
| CN-1073096-A | The preparation of cantharidia liposoluble pharmaceutics | WANG RIWEI (CN) | 1993-06-16 | — | — | CN | claimed |
| US-5167649-A | Drug delivery system for the removal of dermal lesions | ZOOK GERALD P (US) | 1992-12-01 | — | — | US | claimed |
| EP-0506207-A2 | Pharmaceutical vehicles for reducing transdermal flux | CHEMEX PHARMACEUTICALS, Inc. (US) | 1992-09-30 | — | — | EP | claimed |
| CN-1059338-A | The preparation of cantharidia liposoluble pharmaceutics | WANG RIWEI (CN) | 1992-03-11 | — | — | CN | claimed |
| CN-2064039-U | NON-CAUSING WOUND WOMEN'S PROTECTIVE WEAPON | YANG GENYUAN (CN) | 1990-10-17 | — | — | CN | claimed |
| US-4895727-A | Using water soluble zinc compound | CHEMEX PHARMACEUTICALS, INC. (US) | 1990-01-23 | — | — | US | claimed |
| US-4678664-A | POLYETHER BLOCK COPOLYMER | BASF CORPORATION (US) | 1987-07-07 | — | — | US | claimed |
| US-4298752-A | REMOVAL OF WARTS, APHRODISIAC | REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1981-11-03 | — | — | US | claimed |